Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Michael Grayling.

Newcastle AuthorsTitleYearFull text
Dr Ankur Mukherjee
Dr Michael Grayling
Professor James Wason
Adaptive designs: Benefits and cautions for neurosurgery trials2022
Helen Mossop
Dr Michael Grayling
Professor James Wason
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials2022
Dr Michael Grayling
Dr Ben Shillitoe
Dr Malcolm Brodlie
Dr Louise Michaelis
Characterising the allergic profile of children with cystic fibrosis2022
Dr Michael Grayling
Professor James Wason
Conditional power and friends: The why and how of (un)planned, unblinded sample size recalculations in confirmatory trials2022
Dr Michael Grayling
Professor James Wason
Response adaptive intervention allocation in stepped-wedge cluster randomized trials2022
Dr Michael Grayling
Professor James Wason
A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials2021
Dr Graham McClelland
Dr Nina Wilson
Dr Lisa Shaw
Dr Michael Grayling
Professor Christopher Price
et al.
Ambulance documentation of stroke symptoms during the UK COVID-19 ‘Stay at home’ message2021
Dr Michael Grayling
Professor James Wason
Exact group sequential designs for two-arm experiments with Poisson distributed outcome variables2021
Dr Michael Grayling
Professor James Wason
Increasing power in the analysis of responder endpoints in rheumatology: a software tutorial2021
Dr Michael Grayling
Dr Theophile Bigirumurame
Dr Svetlana Cherlin
Luke Ouma
Dr Haiyan Zheng
et al.
Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential2021
Luke Ouma
Dr Michael Grayling
Dr Haiyan Zheng
Professor James Wason
Treatment allocation strategies for umbrella trials in the presence of multiple biomarkers: A comparison of methods2021
Dr Michael Grayling
Professor James Wason
A web application for the design of multi-arm clinical trials2020
Dr Graham McClelland
Dr Nina Wilson
Dr Michael Grayling
Impact of the COVID-19 lockdown on hangings attended by emergency medical services2020
Dr Michael Grayling
A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials2019
Dr Michael Grayling
Professor James Wason
Admissible multiarm stepped-wedge cluster randomized trial designs2019
Dr Michael Grayling
Re-formulating Gehan's design as a flexible two-stage single-arm trial2019
Dr Michael Grayling
Professor James Wason
Two-Stage Adaptive Designs for Three-Treatment Bioequivalence Studies2019
Dr Michael Grayling
Professor James Wason
An optimised multi-arm multi-stage clinical trial design for unknown variance2018
Dr Michael Grayling
Professor James Wason
Blinded and unblinded sample size re-estimation in crossover trials balanced for period2018
Dr Michael Grayling
Professor James Wason
Blinded and unblinded sample size reestimation procedures for stepped-wedge cluster randomized trials2018
Dr Michael Grayling
Calculations involving the multivariate normal and multivariate t distributions with and without truncation2018
Dr Michael Grayling
Professor James Wason
Group Sequential Clinical Trial Designs for Normally Distributed Outcome Variables2018
Dr Michael Grayling
Professor James Wason
Group sequential crossover trial designs with strong control of the familywise error rate2018
Dr Michael Grayling
Professor Jeremy Grimshaw
Reporting of stepped wedge cluster randomised trials: extension of the CONSORT 2010 statement with explanation and elaboration2018
Dr Michael Grayling
Professor James Wason
Group sequential designs for stepped-wedge cluster randomised trials2017
Dr Michael Grayling
Professor James Wason
Stepped wedge cluster randomized controlled trial designs: A review of reporting quality and design features2017